Ströer SE & Co. KGaA Logo

Ströer SE & Co. KGaA

A media company providing integrated out-of-home (OOH) and digital advertising solutions.

SAX | F

Overview

Corporate Details

ISIN(s):
DE0007493991 (+1 more)
LEI:
529900MBF3N1ATE55378
Country:
Germany
Address:
Ströer Allee 1, 50999 Köln
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ströer SE & Co. KGaA is a leading German media company specializing in out-of-home (OOH) advertising, complemented by digital advertising and dialogue marketing. The company provides advertisers with customized, fully integrated marketing solutions through its "OOH plus" strategy, leveraging an extensive portfolio of physical and digital advertising assets, including billboards and street furniture. Ströer's services encompass the entire marketing and sales cycle, offering cross-media campaigns that combine outdoor and online channels. The company also partners with municipalities to integrate its media infrastructure into urban environments, providing public information and cultural services.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-11 00:00
Investor Presentation
Presentation on the Q3 2025 Statement
English 1.3 MB
2025-09-26 09:52
Director's Dealing
Stroer SE & Co. KGaA: Raquel Falomir, buy
English 6.3 KB
2025-09-18 19:36
Earnings Release
Stroer adjusts outlook for financial year 2025
English 6.8 KB
2025-08-13 00:00
Investor Presentation
Presentation on the Half-year financial report 6M/Q2 2025
English 3.1 MB
2025-08-13 00:00
Interim Report
Half-yearly financial report 2025
English 532.1 KB
2025-08-06 13:14
Report Publication Announcement
English 4.0 KB
2025-07-15 17:48
Major Shareholding Notification
English 14.3 KB
2025-05-08 00:00
Investor Presentation
Presentation on the Q1 2025 Statement
English 4.5 MB
2025-04-24 15:05
Pre-Annual General Meeting Information
Stroer SE & Co. KGaA: Bekanntmachung der Einberufung zur Hauptversammlung am 04…
German 91.4 KB
2025-03-24 00:00
Annual Report
Annual financial report 2024
English 2.8 MB
2025-03-13 00:00
Governance Information
Corporate Governance Declaration (03/13/2025)
English 176.0 KB
2025-03-07 00:00
Investor Presentation
Presentation - Preliminary Figures 2024
English 12.4 MB
2025-03-06 17:15
Report Publication Announcement
English 4.7 KB
2025-03-06 00:00
Investor Presentation
Presentation - Preliminary Figures 2024
English 12.4 MB
2025-03-05 17:15
Report Publication Announcement
English 4.7 KB

Automate Your Workflow. Get a real-time feed of all Ströer SE & Co. KGaA filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ströer SE & Co. KGaA

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ströer SE & Co. KGaA via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-05-10 Müller, Udo Board Other None N/A
2023-12-11 Schmalzl, Christian Board Other None 4,727,202.00 EUR
2023-03-22 APM Media GmbH & Co. KG Close relation Other None 8,000,000.00 EUR
2023-01-25 APM Media GmbH & Co. KG Close relation Other None 6,640,000.00 EUR
2023-01-25 CDXX Vermögens- und Verwaltungs GmbH Close relation Buy None 1,026.00 EUR
2023-01-18 Müller, Maximilian Close relation Buy None 23,600.00 EUR
2023-01-17 NEON Equity AG Close relation Buy None 7,025.00 EUR
2023-01-09 Falomir, Raquel Close relation Buy None 229,950.00 EUR
2022-10-13 Müller, Udo Board Buy None 1,030,913.50 EUR
2022-10-04 Müller, Udo Board Other None 4,000,000.00 EUR

Peer Companies

Company Country Ticker View
AngioLab, Inc. Logo
Develops anti-angiogenic therapeutics and foods for angiogenesis-related diseases.
South Korea 251280
Anixa Biosciences Inc Logo
Clinical-stage biotech developing CAR-T immunotherapies and vaccines to fight cancer.
United States of America ANIX
Annovis Bio, Inc. Logo
Developing oral therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.
United States of America ANVS
Aoyama Zaisan Networks Company,Limited Logo
Consulting on inheritance and business succession for individuals and corporations.
Japan 8929
APG SGA SA Logo
Switzerland's leading OOH media firm offering digital and analogue outdoor advertising solutions.
Switzerland APGN.SW
Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.
South Korea 149300
ARM HOLDINGS PLC /UK Logo
Licenses energy-efficient CPU IP for AI, mobile, automotive, IoT, and cloud markets.
United States of America ARM
Arterra Bioscience Logo
Develops natural active ingredients via biotechnology for cosmetic, pharma, and food sectors.
Italy ABS
ARVINAS, INC. Logo
Develops protein degradation drugs for oncology & neuroscience, targeting undruggable proteins.
United States of America ARVN
ASUA Inc. Logo
Consulting and solutions provider enhancing logistics safety and efficiency with IoT and telecom.
Japan 246A

Talk to a Data Expert

Have a question? We'll get back to you promptly.